The Effect of Cancer Associated Fibroblasts(CAFs) and CD44 of CAFs on the Motility of Cancer Cells in Head and Neck Squamous Cell Carcinoma

두경부편평세포암에서 암-연관 섬유아세포가 암세포의 운동성에 미치는 영향과 암-연관 섬유아세포에서 과발현되는 CD44의 역할

  • Shim, Seon-Hui (Department of Molecular Tumor Biology, Seoul National University College of Medicine) ;
  • Hah, J. Hun (Cancer Research Institute, Seoul National University College of Medicine) ;
  • Cho, Soo Youn (Department of Pathology, Korea Cancer Center Hospital) ;
  • Kim, Tae-Min (Department of Internal Medicine, Seoul National University Hospital) ;
  • Koh, Young-Il (Department of Internal Medicine, Seoul National University Hospital) ;
  • Kim, Dong-Wan (Cancer Research Institute, Seoul National University College of Medicine) ;
  • Lee, Choon-Taek (Department of Medicine and Respiratory Center, Seoul National University Bundang Hospital) ;
  • Heo, Dae Seog (Department of Molecular Tumor Biology, Seoul National University College of Medicine) ;
  • Sung, Myung-Whun (Department of Molecular Tumor Biology, Seoul National University College of Medicine)
  • 심선희 (서울대학교 의과대학 분자종양생물학교실) ;
  • 하정훈 (서울대학교 의과대학 암연구소) ;
  • 조수연 (서울대학교 의과대학 원자력병원 병리과) ;
  • 김태민 (서울대학교병원 내과) ;
  • 고영일 (서울대학교병원 내과) ;
  • 김동완 (서울대학교 의과대학 암연구소) ;
  • 이춘택 (서울대학교분당병원 내과 및 폐센터) ;
  • 허대석 (서울대학교 의과대학 분자종양생물학교실) ;
  • 성명훈 (서울대학교 의과대학 분자종양생물학교실)
  • Received : 2014.09.29
  • Accepted : 2014.10.02
  • Published : 2014.10.31

Abstract

배경 및 목적 암-연관 섬유아세포(Cancer-associated fibroblasts, CAF)는 종양미세환경의 가장 중요한 요소의 하나다. 그래서 두경부편평세포암에 대해 CAF가 암세포의 운동성에 미치는 영향을 평가하고, CAF에 과발현되는 CD44의 역할에 대해 평가하고자 하였다. 재료 및 방법 두경부암환자의 종양조직에서 CAF를 분리하고, 비종양성 조직으로부터 정상 섬유아세포(NHF)를 분리하였다. 창상치유분석과 상하 챔버를 이용한 3차원 세포 이동 분석을 이용하여, CAF가 암세포의 이동에 미치는 영향을 분석하고, CAF에서 과발현되는 CD44를 중화항체로 CAF를 차단했을 때 암세포 이동의 변화를 관찰하였다. 결과 NHF에 비해 CAF에서 CD44가 과발현되는 것을 관찰하였다. 창상치유분석에서 CAF와 같이 배양된 암세포는 NHF와 같이 배양된 암세포에 비해 더 빠른 이동을 보였다. CD44 중화 항체를 처리했을 때는 암세포의 이동성이 저해되었다. 결론 CAF는 종양미세환경에서 암세포의 운동성을 조절하는 중요한 인자의 하나일 것으로 사료된다. CD44는 CAF의 기능을 매개하는 중요한 표지자 중 하나로 생각된다.

Keywords

References

  1. Sherman L, Sleeman J, Dall P, Hekele A, Moll J, Ponta H, et al. The CD44 proteins in embryonic development and in cancer. Curr Top Microbiol Immunol. 1996;213(Pt 1):249-269.
  2. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol. 2007;170(6):1807-1816. https://doi.org/10.2353/ajpath.2007.070112
  3. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature. 2004;432(7015):332-337. https://doi.org/10.1038/nature03096
  4. Ostman A, Augsten M. Cancer-associated fibroblasts and tumor growth--bystanders turning into key players. Curr Opin Genet Dev. 2009;19(1):67-73. https://doi.org/10.1016/j.gde.2009.01.003
  5. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392-401. https://doi.org/10.1038/nrc1877
  6. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005;121(3):335-348. https://doi.org/10.1016/j.cell.2005.02.034
  7. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990;61(7):1303-1313. https://doi.org/10.1016/0092-8674(90)90694-A
  8. Acharya PS, Majumdar S, Jacob M, Hayden J, Mrass P, Weninger W, et al. Fibroblast migration is mediated by CD44-dependent TGF beta activation. J Cell Sci. 2008;121(Pt 9):1393-1402. https://doi.org/10.1242/jcs.021683
  9. Foster LC, Arkonac BM, Sibinga NE, Shi C, Perrella MA, Haber E. Regulation of CD44 gene expression by the proinflammatory cytokine interleukin-1beta in vascular smooth muscle cells. J Biol Chem. 1998;273(32):20341-20346. https://doi.org/10.1074/jbc.273.32.20341
  10. Legg JW, Lewis CA, Parsons M, Ng T, Isacke CM. A novel PKC-regulated mechanism controls CD44 ezrin association and directional cell motility. Nat Cell Biol. 2002;4(6):399-407. https://doi.org/10.1038/ncb797
  11. Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev. 2001;15(8):968-980. https://doi.org/10.1101/gad.189601
  12. Marhaba R, Zoller M. CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol. 2004;35(3):211-231.
  13. Godar S, Ince TA, Bell GW, Feldser D, Donaher JL, Bergh J, et al. Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression. Cell. 2008;134(1):62-73. https://doi.org/10.1016/j.cell.2008.06.006
  14. Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY. CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope. 2009;119(8):1518-1530. https://doi.org/10.1002/lary.20506
  15. Prince ME, Ailles LE. Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol. 2008;26(17):2871-2875. https://doi.org/10.1200/JCO.2007.15.1613
  16. Ward RJ, Dirks PB. Cancer stem cells: at the headwaters of tumor development. Annu Rev Pathol. 2007;2:175-189. https://doi.org/10.1146/annurev.pathol.2.010506.091847
  17. Jenq RR, van den Brink MR. Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Nat Rev Cancer. 2010;10(3):213-221. https://doi.org/10.1038/nrc2804
  18. Messadi DV, Bertolami CN. CD44 and hyaluronan expression in human cutaneous scar fibroblasts. Am J Pathol. 1993;142(4):1041-1049.
  19. Dong-Le Bourhis X, Berthois Y, Millot G, Degeorges A, Sylvi M, Martin PM, et al. Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int J Cancer. 1997;71(1):42-48. https://doi.org/10.1002/(SICI)1097-0215(19970328)71:1<42::AID-IJC9>3.0.CO;2-3
  20. Fujita H, Ohuchida K, Mizumoto K, Egami T, Miyoshi K, Moriyama T, et al. Tumor-stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells. Cancer Sci. 2009;100(12):2309-2317. https://doi.org/10.1111/j.1349-7006.2009.01317.x